美国 · SEC FORM 4
GLAUKOS Corp
GKOS · NYSE · CIK 0001192448 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
53 同一窗口内观察到的 Form 4 交易行
32 sales · 21 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,850,422
- 上期报告
- 4,166,410
- 日均成交量
- 944,395
- 回补天数
- 4.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
139 transaction lines in the latest 365-day window; 691 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Navratil Tomas | 卖出 (S) | Common Stock | 1,527 | USD 164.45 | USD 251,120 | SEC 申报 ↗ |
| 2026-09-25 | Navratil Tomas | 卖出 (S) | Common Stock | 1,615 | USD 154.28 | USD 249,158 | SEC 申报 ↗ |
| 2026-09-16 | Navratil Tomas | 卖出 (S) | Common Stock | 1,457 | USD 166.92 | USD 243,204 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Navratil Tomas | 卖出 (S) | Common Stock | 1,527 | USD 164.45 | USD 251,120 | SEC 申报 ↗ |
| 2026-09-25 | Navratil Tomas | 卖出 (S) | Common Stock | 1,615 | USD 154.28 | USD 249,158 | SEC 申报 ↗ |
| 2026-09-16 | Navratil Tomas | 卖出 (S) | Common Stock | 1,457 | USD 166.92 | USD 243,204 | SEC 申报 ↗ |
| 2026-08-28 | Navratil Tomas | 卖出 (S) | Common Stock | 13,744 | USD 180.67 | USD 2,483,104 | SEC 申报 ↗ |
| 2026-08-19 | Kliman Gilbert H | 卖出 (S) | Common Stock | 2,500 | USD 190.00 | USD 475,000 | SEC 申报 ↗ |
| 2026-08-19 | Kliman Gilbert H | 期权行权／转换 (M) | Common Stock | 2,500 | USD 25.77 | USD 64,425 | SEC 申报 ↗ |
| 2026-08-11 | Gilliam Joseph E | 卖出 (S) | Common Stock | 60,000 | USD 179.74 | USD 10,784,659 | SEC 申报 ↗ |
| 2026-08-11 | Gilliam Joseph E | 期权行权／转换 (M) | Common Stock | 30,000 | USD 52.94 | USD 1,588,200 | SEC 申报 ↗ |
| 2026-08-07 | Thurman Alex R. | 卖出 (S) | Common Stock | 20,000 | USD 180.13 | USD 3,602,600 | SEC 申报 ↗ |
| 2026-08-07 | Thurman Alex R. | 期权行权／转换 (M) | Common Stock | 20,000 | USD 33.81 | USD 676,200 | SEC 申报 ↗ |
| 2026-07-31 | WEN LEANA | 卖出 (S) | Common Stock | 525 | USD 167.63 | USD 88,006 | SEC 申报 ↗ |
| 2026-07-16 | Thurman Alex R. | 卖出 (S) | Common Stock | 10,000 | USD 160.00 | USD 1,600,000 | SEC 申报 ↗ |
| 2026-07-16 | Thurman Alex R. | 期权行权／转换 (M) | Common Stock | 10,000 | USD 38.68 | USD 386,800 | SEC 申报 ↗ |
| 2026-07-09 | Thurman Alex R. | 卖出 (S) | Common Stock | 10,000 | USD 155.00 | USD 1,550,000 | SEC 申报 ↗ |
| 2026-07-09 | Thurman Alex R. | 期权行权／转换 (M) | Common Stock | 10,000 | USD 38.68 | USD 386,800 | SEC 申报 ↗ |
| 2026-07-06 | Thurman Alex R. | 卖出 (S) | Common Stock | 10,000 | USD 150.00 | USD 1,500,000 | SEC 申报 ↗ |
| 2026-07-06 | Thurman Alex R. | 期权行权／转换 (M) | Common Stock | 10,000 | USD 38.68 | USD 386,800 | SEC 申报 ↗ |
| 2026-07-01 | Navratil Tomas | 卖出 (S) | Common Stock | 716 | USD 139.06 | USD 99,567 | SEC 申报 ↗ |
| 2026-06-25 | Navratil Tomas | 代扣税 (F) | Common Stock | 483 | USD 142.57 | USD 68,861 | SEC 申报 ↗ |
| 2026-06-25 | Gilliam Joseph E | 代扣税 (F) | Common Stock | 1,056 | USD 142.57 | USD 150,554 | SEC 申报 ↗ |
| 2026-06-25 | Burns Thomas William | 代扣税 (F) | Common Stock | 4,059 | USD 142.57 | USD 578,692 | SEC 申报 ↗ |
| 2026-06-16 | Navratil Tomas | 卖出 (S) | Common Stock | 1,537 | USD 130.68 | USD 200,855 | SEC 申报 ↗ |
| 2026-05-28 | WEN LEANA | 奖励／授予 (A) | Common Stock | 1,878 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-28 | WEISNER AIMEE S | 奖励／授予 (A) | Common Stock | 1,878 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-28 | Torres Denice | 奖励／授予 (A) | Common Stock | 1,878 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-28 | Stapley Marc | 奖励／授予 (A) | Common Stock | 1,878 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-28 | Kliman Gilbert H | 奖励／授予 (A) | Common Stock | 1,878 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-28 | Hoffmeister David F | 奖励／授予 (A) | Common Stock | 1,878 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-28 | Foley Mark J | 奖励／授予 (A) | Common Stock | 1,878 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | Hoffmeister David F | 期权行权／转换 (M) | Common Stock | 15,000 | USD 24.69 | USD 370,350 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | GKOS |
| CIK | 0001192448 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 691 transaction lines from 2020-01-02 to 2026-10-05 0 P purchase lines · 227 S sale lines · 464 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.